More Women are Choosing Personalized Medicine

Written by Carol Petersen, RPh, CNP - Women's International Pharmacy

 

Dr. JoAnn Pinkerton was the lead author for a paper entitled, "Compounded Bioidentical Hormone Therapy: Identifying Use Trends and Knowledge Gaps among U.S. Women" recently published in Menopause, the journal of the North American Menopause Society (NAMS).

 

The paper evaluated two studies that involved answering questionnaires via internet invitations. The first study analyzed data for 801 women reporting at least one menopausal symptom and the second study looked at data for women who were ever users of hormone therapies. The paper raised great concern because a low number of respondents using compounded bioidentical hormone therapies answered correctly when asked if they knew that their therapies were not FDA approved. Interestingly, the women who took manufactured hormone therapies were not asked about their knowledge of whether their therapies were FDA approved. Therefore, one cannot determine if the women using manufactured hormone therapies would have answered the same question correctly.  


Bias is of significant concern in this paper considering the source of the funding is a pharmaceutical company focused on the development and commercialization of FDA approved hormone replacement products. 

 

 Continue Reading

Quality Assurance at Women's International Pharmacy

 

Women's International Pharmacy is committed to providing superior custom compounded bioidentical hormones for both men and women. We have been filling prescriptions since 1985 with precision and unwavering quality. Please don't keep us a secret J!

 

 

UCLA Pioneers a New Treatment Program to Improve Memory Loss


Written by Kathy Lynch, PharmD - Women's International Pharmacy


 
In spite of hundreds of clinical trials over the past 10 years, Alzheimer's disease (AD) has no effective treatment. AD affects 5.4 million Americans predominately females. It is estimated that women have a greater chance of developing AD than breast cancer. 

Pharmacist Corner

 

Research supports the theory that an imbalance in brain nerve cell signals causes this disorder. Specific signals make nerve connections to cement memories while others allow irrelevant memories to be lost. This signaling system becomes imbalanced so that new memory connections are inhibited while more information is forgotten. Reversible metabolic processes may be involved in the early stages of AD.

 

Dr Bredeson and his colleagues at UCLA believe that a comprehensive, personalized approach is the best way to treat memory loss. They have developed a program that optimizes diet (no simple carbohydrates, gluten or processed foods), utilizes meditation and yoga, and emphasizes the importance of sleep, hormones, good oral health and exercise.  Patients may use supplements as well as medium chain triglycerides like coconut oil or Axona.

 

The researchers believe that free T3 and T4, estradiol, testosterone, progesterone, pregnenolone and cortisol need to be optimized.

 

9 out of 10 patients in this pilot program had cognitive improvement.

 

Reference:

"Memory loss associated with Alzheimer's reversed for first time"

http://newsroom.ucla.edu/releases/memory-loss...  

Dale Bredesen. "Reversal of cognitive decline: A novel therapeutic program."

Aging; Sept 2014; 6(9): 707 - 717.


 
Sincerely,

 

Women's International Pharmacy

 www.womensinternational.com 

___________________________________________________________

 
Join Our Mailing List

In This Issue
More Women are Choosing Personalized Medicine
Quality Assurance at Women's International Pharmacy
UCLA Pioneers a New Treatment Program to Improve Memory Loss

Upcoming Events

We are exhibiting at the following conferences:

 


Visit our website for our full conference schedule